Get started
Author

E M Fenyö

Observed names: E FENYO, E M Fenyo, E-M. FENYÖ, E. M. FENYÖ, E. M. Fenyo, E. M. Fenyö, E.-M. Fenyö, E.M. Fenyö, Eva Maria Fenyö, Eva Maria Feny�, Eva Marie Fenyö
Observed institutions: Statens Serum Institut, United Nations, Lund University, Instituto de Salud Carlos III, Hvidovre Hospital, Rigshospitalet, Karolinska Institutet, Frederick National Laboratory for Cancer Research, National Cancer Institute, Imperial College London, KTH Royal Institute of Technology
OpenAlex ID: A5111687396
A new classification for HIV-1
1998 · E. A. Berger, R. W. Doms, et al. · Nature · 861
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
1997 · A Björndal, H Deng, et al. · Journal of Virology · 612
Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1
1990 · S Schwartz, B K Felber, et al. · Journal of Virology · 435
PDF
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
1988 · E M Fenyö, L Morfeldt-Månson, et al. · Journal of Virology · 434
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs
1990 · S Schwartz, B K Felber, et al. · Journal of Virology · 263
PDF
Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers
1990 · J Albert, E M Fenyö · Journal of Clinical Microbiology · 246
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.
1993 · G Scarlatti, T Leitner, et al. · Proceedings of the National Academy of Sciences · 182
MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection
1994 · A Karlsson, K Parsmyr, et al. · Journal of Clinical Microbiology · 157
Analysis of heterogeneous viral populations by direct DNA sequencing.
1993 · T Leitner, E Halapi, et al. · PubMed · 157
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
1992 · P A Broliden, A von Gegerfelt, et al. · Proceedings of the National Academy of Sciences · 115
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
1987 · K Ljunggren, B Böttiger, et al. · The Journal of Immunology · 113
Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization
1996 · J Weber, E M Fenyö, et al. · Journal of Virology · 110
Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
1994 · A Valentin, J Albert, et al. · Journal of Virology · 99
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals
1992 · F Chiodi, B Keys, et al. · Journal of Clinical Microbiology · 80
PDF
Fusion of Tumour Cells with Host Cells
1972 · F. WIENER, E. M. FENYÖ, et al. · Nature New Biology · 65
Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.
1989 · S Schwartz, B K Felber, et al. · Proceedings of the National Academy of Sciences · 64
Screening of HIV-1 Env Glycoproteins for the Ability to Raise Neutralizing Antibody Using DNA Immunization and Recombinant Vaccinia Virus Boosting
1997 · J.F.L. Richmond, F. Mustafa, et al. · Virology · 62
PDF
Coreceptor Change Appears after Immune Deficiency Is Established in Children Infected with Different HIV-1 Subtypes
2002 · C. Casper, L. Navér, et al. · AIDS Research and Human Retroviruses · 52
Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
1989 · K Ljunggren, A Karlson, et al. · PubMed · 47
Isolation of Human Immunodeficiency Virus From Cerebrospinal Fluid of Antibody-positive Virus Carrier Without Neurological Symptoms
1986 · F CHIODI, B Asjö, et al. · The Lancet · 47
Functional Characterization of the V1V2 Region of Human Immunodeficiency Virus Type I
1996 · C. PALMER, P. BALFE, et al. · Virology · 46
PDF
Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture
1993 · S Sánchez-Palomino, J M Rojas, et al. · Journal of Virology · 46
Cell-surface antigens induced by RNA tumour viruses
1979 · R. Kurth, E. M. Fenyö, et al. · Nature · 43
Radioimmunoprecipitation and Western Blotting with Sera of Human Immunodeficiency Virus Infected Patients: A Comparative Study
1987 · F. Chiodi, U. Bredberg-Råden, et al. · AIDS Research and Human Retroviruses · 41
The immune response to primary moloney sarcoma virus tumors in BALB/C mice: Cellular and humoral activity of long‐term regressors
1974 · E. W. Lamon, B. Andersson, et al. · International Journal of Cancer · 35
Works count: 46
Citation count: 4,728
H-index: 28
I10-index: 39
Year
Topic
Type